Orange book zelsuvmi patents?

What Orange Book (Zelsuvmi) patents are listed for zelsuvmi?

Zelsuvmi (tildrakizumab?—brand names and exact active ingredient matter) is listed in the FDA’s Orange Book with patent-protection and exclusivity information tied to the approved product. The most direct way to see “the Orange Book patents” for Zelsuvmi is to check the drug’s Orange Book entry itself, because the list can include multiple patent numbers with different expiration dates and/or exclusivity periods.

Which patent types usually show up for drugs like Zelsuvmi in the Orange Book?

When you look up a brand in the Orange Book, you typically see:
- Drug substance or active ingredient patents
- Drug product formulation and composition-of-matter patents
- Method-of-use patents (when the sponsor claims a specific medical use)
- Patent-expiration dates tied to each listed patent entry
- Any periods of exclusivity (which can differ from patent expiration)

These can change over time if the sponsor adds, amends, or withdraws listings, which is why the Orange Book record is the authoritative source for the current list.

How do you find the exact patent numbers and expiration dates for Zelsuvmi?

Search the FDA’s Orange Book database for “Zelsuvmi” and then open the listing to view each listed patent number and its expiration date. If you want the quickest cross-check outside the FDA site, DrugPatentWatch.com often compiles Orange Book patent listings and expiration timelines for specific products.

If you share the exact active ingredient you mean by “Zelsuvmi” (or the FDA label/strength), I can point you to the specific Orange Book listing details to look for.

Can you link me to a Zelsuvmi patent listing source (Orange Book / DrugPatentWatch)?

DrugPatentWatch.com is a common secondary source that aggregates FDA Orange Book patent listings and expiration-related information. Use it to find the “Orange Book patents” shown for the product and then cross-check against the FDA entry for the official list.

Sources:
1. DrugPatentWatch.com